Figure 3
5α-Reduced glucocorticoid binds and selectively activates GR. (A) 5α-Tetrahydrocorticosterone (5αTHB) and 5α-dihydrocorticosterone
(5αDHB) (overnight incubation with concentration range from 10−5 to 10−9 M) displaced tritiated dexamethasone (100 nM) from glucocorticoid receptors in rat hepatic cytosol. The Kds for binding of 5αTHB (268 nM) and 5αDHB (336 nM) were similar to that of corticosterone (153 nM) and higher than dexamethasone
(38 nM; n=6/treatment). (B) 5αTHB, but not 5αDHB, induced transcription of tyrosine aminotransferase (TAT) to a lesser extent than
corticosterone (B) when incubated for 24 h in H4iiE cells (rat hepatoma cells). Abundance of transcript was quantified by
northern blot and normalised for that of U1, n=6/treatment. *P<0.05 vs vehicle (veh), #P<0.05 vs B. Following chronic infusion of steroids (50 μg/day, 2 weeks) to mice (n=10–12/group): (C) corticosterone, but not 5αTHB, impaired glucose tolerance, as demonstrated by increased insulin concentrations
(P<0.001 vs vehicle) after a glucose tolerance test (2 g/kg body weight i.p.) performed in mice following a 6 h fast. Insulin
was quantified by immunoassay. (D) 5αTHB caused immune suppression to a similar extent to corticosterone, assessed by a significant
reduction (P<0.01) in the ability of lipopolysaccharide (LPS; 0.01–100 ng/ml)) to induce release of interleukin 6 (IL6) following incubation
(24 h) from cells in whole blood harvested at cull. IL6 was quantified by immunoassay. Data are mean±s.e.m. Data presented in A and B are adapted from those originally published in the McInnes KJ, Kenyon CJ, Chapman KE, Livingstone
DEW, Macdonald LJ, Walker BR & Andrew R 2004 5α-Reduced glucocorticoid metabolites, novel endogenous activators of glucocorticoid
receptors (GR). Journal of Biological Chemistry 279 22908–22912 © the American Society for Biochemistry and Molecular Biology. Data presented in C and D were originally published
in the Yang CA, Nixon M, Kenyon CJ, Livingstone DEW, Duffin R, Rossi AG, Walker BR & Andrew R 2011 5α-Reduced glucocorticoids
exhibit dissociated anti-inflammatory and metabolic effects. British Journal of Pharmacology. (In press) (doi:10.1111/j.1476-5381.2011.01465.x).